MyFinsight
Home
Blog
About
Proceeds from long term
debt, net of issuance...
$96,699K
Proceeds from issuance of
common stock pursuant...
$1,793K
Net cash provided by
financing activities
$1,005K
Canceled cashflow
$97,487K
Net decrease in
cash, cash...
-$33,606K
Canceled cashflow
$1,005K
Depreciation and
amortization expense
$6,714K
Stock-based compensation
expense
$6,342K
Other
$1,123K
Accounts payable and
accrued expenses
$602K
Acquisition of business, net
of cash acquired
-$33,195K
Proceeds from maturities
of marketable...
$11,975K
Proceeds from sales of
marketable securities
$1,397K
Proceeds from offerings,
net of issuance...
-$96,998K
Finance lease principal
payments
$489K
Net cash (used in)
provided by operating...
-$28,981K
Net cash used in
investing activities
-$5,630K
Canceled cashflow
$14,781K
Canceled cashflow
$46,567K
Net (loss) income
-$17,740K
Other assets and
liabilities
$10,896K
Accounts receivable
$6,682K
something is missing
-$33,195K
Inventory
$5,662K
Change in third party
payor reserves
$2,044K
Deferred tax expense
-$518K
Change in fair value of
financial liabilities
-$220K
Purchases of property and
equipment and development...
$10,114K
Purchases of marketable
securities
$8,888K
Back
Back
Cash Flow
GeneDx Holdings Corp. (WGSWW)
GeneDx Holdings Corp. (WGSWW)
source: myfinsight.com